2018 Bioelectronic Medicine Forum
A New Investment and Management Conference for
Entrepreneurs and Executives
March 22, 2018
Millennium Broadway, New York, NY
This inaugural meeting represents the first management and investment conference for the new and emerging bioelectronic medicine industry. Attendees will have an exclusive opportunity to interact with some of the key leaders driving this field forward. The schedule of presentations and panel discussions features a host of experts with a wealth of information on the neuroscience industry and the investment community.
Featured speakers include Gene Civillico, Ph.D., the NIH Program Manager for the SPARC program, which has funded much of the early research in this field. Also presenting is Eric van Gieson, Ph.D., Program Manager at DARPA's Biological Technologies Office, which oversees the ElectRx program.
Sessions will cover a range of technologies and indications for bioelectronic medicine, including applications in cardiovascular medicine, inflammation, gastrointestinal disorders, and many other clinical specialties. Attendees will hear from some of the leading researchers and entrepreneurs developing clinically and commercially promising products such as implanted vagus nerve stimulation systems to treat hypertension, and surface stimulation devices to treat a range of disorders.
The conference is co-sponsored by Action Potential Venture Capital, the venture firm backed by GlaxoSmithKline that has led investment in several key startups in the bioelectronic medicine industry. APVC Partner Imran Eba will serve as co-chair and conference director. The Feinstein Institute for Medical Research is also co-sponsoring this meeting.
For information on sponsorship opportunities, visit this link: